-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on Eli Lilly, Maintains $1600 Price Target

Benzinga·11/17/2026 14:31:15
Listen to the news
RBC Capital analyst Trung Huynh reiterates Eli Lilly (NYSE:LLY) with a Outperform and maintains $1600 price target.